	From Theory to Therapy: The Evolution and Future of Cognitive-Behavioral Therapy for Psychosis in U.S. Mental Health Care. Focus (Am Psychiatr Publ) Kopelovich SL, Brown P, Hardy K. PMID: 41613750 [PubMed]
	Why Not Rock the Boat? Deprescribing Anticholinergic Medications That Are No Longer Needed in Persons With Schizophrenia. Focus (Am Psychiatr Publ) Gannon JM, Chengappa KNR, Lupu AM, Brar JS. PMID: 41613749 [PubMed]
	Xanomeline-Trospium for the Treatment of Schizophrenia. Focus (Am Psychiatr Publ) Ehret MJ, Meyer JM. PMID: 41613741 [PubMed]
	Smartphone Apps and Digital Tools for Managing Schizophrenia and Psychotic Disorders: A Clinical Review. Focus (Am Psychiatr Publ) Xia W, Hau C, Firth J, Kimhy D, Torous J. PMID: 41613740 [PubMed]
	The Role of Amphiregulin and Epidermal Growth Factor Receptor in First-Episode Psychosis: Exploring Links to Schizophrenia Pathophysiology. Noro Psikiyatr Ars Ta, Ye, Ç, Karamustafal. PMID: 41613037 [PubMed]
	Correction: Transition rates to schizophrenia and early intervention effectiveness in substance-induced and brief psychotic disorders: a randomized controlled trial. Sci Rep Abouzed M, Gabr A, Elsheikh M, Elag KA, Zeid MY, Barakat M, Elasaly E, Elsaadouni N, Soliman M. PMID: 41611941 [PubMed - in process]
	Parsing the neuroanatomy of schizophrenia to enhance the translational validity of preclinical models - a multidisciplinary perspective. Prog Neuropsychopharmacol Biol Psychiatry Morris BJ. PMID: 41611010 [PubMed - as supplied by publisher]
	Small EVs miRNA profiles and their expressions in EVs-depleted plasma as an optimal combination panel for treatment-resistant schizophrenia. Schizophr Res Chen BY, Lin JJ, Tseng HH, Huang CC, Chen PS, Li CH, Yao CY, Cheng WL, Wang TY, Jang FL, Lin SH. PMID: 41610752 [PubMed - as supplied by publisher]
	A comparative study of medication adherence in schizophrenia patients receiving clozapine and other antipsychotics. Psychiatry Res Chanalia S, Grover S, Chakrabarti S. PMID: 41610565 [PubMed - as supplied by publisher]
	New Pharmacological Treatment Approaches for Schizophrenia: Navigating the Post-iclepertin Landscape. CNS Drugs Englisch S, Zink M. PMID: 41609993 [PubMed - as supplied by publisher]
	An observational study on the effects of as-needed use of various antipsychotic drugs for agitation due to psychotic disorders. Int Clin Psychopharmacol Hatta K, Morikawa F, Yamasaki S, Ishizuka T, Nakamura M, Hino K, Katayama S, Imai A, Fujita K, Sugiyama N, JAST study group. PMID: 41609240 [PubMed - as supplied by publisher]
	Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials. Ther Adv Psychopharmacol Anand R, Turolla A, Chinellato G, Sansi F, Roy A, Hartman R. PMID: 41607530 [PubMed]
	Impact of Offender Schizophrenia Diagnosis on Public Perceptions of Crime and Punishment. Behav Sci Law Queen MM, Goncy E. PMID: 41607359 [PubMed - as supplied by publisher]
	Mapping intrinsic brain activity and multilevel mechanisms underlying auditory verbal hallucinations in schizophrenia: A systematic review and meta-analysis. Neurosci Biobehav Rev Xie Y, Zhang T, Ouyang A, Muzhen G, Lin X, Wang L, Diao X, Li Y, He W, Dong Q, Zeng L, Li C, Wang H, Fang P. PMID: 41605340 [PubMed - as supplied by publisher]
	Prototypical Representation Learning for Multi-Site Domain Generalization in Schizophrenia Diagnosis. IEEE Trans Biomed Eng Ji Y, Calhoun VD, Zhang J, Zhu Q, Li S, Mathalon DH, Yeo S, Zhang D, Qi S. PMID: 41605185 [PubMed - as supplied by publisher]
	Assessment of phase-locking factor with visual area-targeted transcranial magnetic stimulation-electroencephalography shows reduced connectivity in schizophrenia: A preliminary study. Psychiatry Res Neuroimaging Ide M, Tadamura A, Miyazaki T, Inoue Y, Sekine A, Takahashi T, Tamura M, Matsuzaki A, Nemoto K, Tachikawa H, Arai T, Kawasaki M. PMID: 41604986 [PubMed - as supplied by publisher]
	National and State Societal Costs of Schizophrenia in the US in 2024. JAMA Psychiatry Krasa HB, Baumgardner JR, Brewer IP, Chou JW, Flottemesch T, Markowitz JT, Williams C, Nagendra A. PMID: 41604174 [PubMed - as supplied by publisher]
	Correction: Effects of gut microbiota interventions on patients with schizophrenia: a systematic review and meta-analysis. Front Microbiol Ye N, Song X, Yu J, Bao X, Ye M, Jiang L. PMID: 41602749 [PubMed]
	Development of a supportive mHealth device for persons with schizophrenia spectrum disorders (KisoLight(App)): a usability study within a participant-involvement principle. Front Psychol Fässler L, Ersöz B, Hahne I, Koop S, Böge K. PMID: 41602658 [PubMed]
	Application of cerebellar vermis theta-burst stimulation patterned repetitive transcranial magnetic stimulation in patients with chronic schizophrenia. Front Psychiatry Lei S, Lei Q, Yang J, Peng H, Feng J. PMID: 41601524 [PubMed]

Articles 1 - 20 / 67907

Page 1 of 3396



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy